GENERIC AADHAAR CASE STUDY

GENERIC AADHAAR CASE STUDY, FUNDING, BUSINESS MODEL, REVENUE MODEL, INVESTORS, COMPETITOR

GENERIC AADHAAR CASE STUDY, FUNDING, BUSINESS MODEL, REVENUE MODEL, INVESTORS, COMPETITOR

GENERIC AADHAAR CASE STUDY, FUNDING, BUSINESS MODEL, REVENUE MODEL, INVESTORS, COMPETITOR

Founder and CEO: Arjun Deshpande

GENERIC AADHAAR CASE STUDY, FUNDING, BUSINESS MODEL, REVENUE MODEL, INVESTORS, COMPETITOR

GENERIC AADHAAR BUSINESS MODEL

Generic Aadhaar is a Mumbai based B2B and B2C pharma startup that supplies quality generic drugs directly from the reputed manufacturer at up to 80 percent lesser cost.

GENERIC AADHAAR CASE STUDY, FUNDING, BUSINESS MODEL, REVENUE MODEL, INVESTORS, COMPETITOR

STORY BEHIND THE IDEA GENERIC AADHAAR

By the time he turned 14 years old, Arjun Deshpande had visited more than 20 plants with his mother, who was in the pharma trade. During those visits, Arjun, a computer enthusiast, and his mother spoke about the medicine business in India.

He soon learned that India was one of the few countries where generic drugs were as expensive as branded medicines. The reasons were two: lack of awareness among people and the fact that the wholesale industry sought high margins from small retailers, increasing pricing for consumers.

In 2018, he founded Thane-based Generic Aadhaar, a pharma startup that provides generic quality medicines from reputed pharma companies at up to 80 percent lesser prices. It offers a huge portfolio of branded, generic, homeopathy, and Ayurveda medicines from the government-approved manufacturing facilities.

Over the next three years, he borrowed Rs 15 lakh from his family to build Generic Aadhaar.

GENERIC AADHAAR CASE STUDY, FUNDING, BUSINESS MODEL, REVENUE MODEL, INVESTORS, COMPETITOR

GENERIC AADHAAR FUNDING

Ratan Tata invested an undisclosed amount in pharmaceutical venture Generic Aadhaar.

INVESTORS

Ratan Tata.

GENERIC AADHAAR CASE STUDY, FUNDING, BUSINESS MODEL, REVENUE MODEL, INVESTORS, COMPETITOR

DISCOVER

FOUNDED: 2018

CEO: Arjun Deshpande

HEADQUARTERS: Thane, Mumbai

ESTIMATED ANNUAL REVENUE: Rs 6 crore

Industry Sector: Pharmacy

STORES: over 25 in Mumbai.

TIED UP COMPANIES: Over 10 manufacturing companies. 

FRANCHISEE: Available

HOME DELIVERY: Free

Thanks for reading

GENERIC AADHAAR CASE STUDY, FUNDING, BUSINESS MODEL, REVENUE MODEL, INVESTORS, COMPETITOR

Subscribe To Get latest update

share your startup story and inspire all